Molecular imaging probes for 31P contrast
<p><sup>31</sup>P magnetic resonance has yet to realise its clinical potential principally due to the relatively low sensitivity of the <sup>31</sup>P nucleus. While <sup>31</sup>P-MRS can uniquely provide vital information regarding in vivo phosphorus met...
Yazar: | Tear, L |
---|---|
Diğer Yazarlar: | Faulkner, S |
Materyal Türü: | Tez |
Dil: | English |
Baskı/Yayın Bilgisi: |
2018
|
Konular: |
Benzer Materyaller
-
Glucosamine Conjugated Gadolinium (III) Oxide Nanoparticles as a Novel Targeted Contrast Agent for Cancer Diagnosis in MRI
Yazar:: T Mortezazadeh, ve diğerleri
Baskı/Yayın Bilgisi: (2020-02-01) -
Magnetic Resonance Imaging Contrast Agents: A Review of Literature
Yazar:: Zahra Sahraei, ve diğerleri
Baskı/Yayın Bilgisi: (2015-10-01) -
Interval between contrast administration and T1-weighted MRI for cerebral adrenoleukodystrophy: a single-case observation
Yazar:: Marco Moscatelli, ve diğerleri
Baskı/Yayın Bilgisi: (2023-10-01) -
Image quality of late gadolinium enhancement in cardiac magnetic resonance with different doses of contrast material in patients with chronic myocardial infarction
Yazar:: Caterina Beatrice Monti, ve diğerleri
Baskı/Yayın Bilgisi: (2020-04-01) -
Macrocyclic MR contrast agents: evaluation of multiple-organ gadolinium retention in healthy rats
Yazar:: Simona Bussi, ve diğerleri
Baskı/Yayın Bilgisi: (2020-02-01)